|Articles|December 25, 2020
NeurologyLive Friday 5 — December 25, 2020
Author(s)NeurologyLive® Staff
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending December 25, 2020.
Advertisement
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: Expert Perspectives: Recent Approvals for Acute Migraine
Expert physicians consider the recent treatment approvals for the management of acute migraine, and how the shift in expectations outcomes has impacted treatment selection.
2: Reflections on the Impact of COVID-19: A Short Expert Series
This specialty series is dedicated to assessing the impact COVID-19 has had on the quality of life of patients with neurological disorders and the clinicians who were forced to adapt during this unique era of medical history.
3: Sleep Deprivation Among Frontline Health Care Workers During COVID-19 Turns Critical
The pandemic's impact stretches across all aspects of life and has particularly concerning effects on the sleep of those working on the frontlines providing care of patients.
4: Insights: Treatment Options for Dravet Syndrome
M. Scott Perry, MD, discusses historically approved therapies for the first-, second-, and third-line treatment of Dravet syndrome.
5: A Team Approach to Asleep Deep Brain Stimulation
Jason M. Schwalb, MD; Ellen L. Air, MD, PhD; Neepa J. Patel, MD; and Julia A. Wall discuss Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care that has helped it become a leading treatment center for Parkinson disease and related movement disorders.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- NeurologyLive® Friday 5 — September 12, 2025
September 12th 2025
- Expanding the Alzheimer Drug Development Pipeline
September 12th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
MDA and PPMD Release Consensus Guidelines for Safe and Equitable Use of Gene Therapy in Duchenne
2
Expanding the Alzheimer Drug Development Pipeline
3
DORAs Carry Lower Real-World Abuse, New Phase 3 Argus Data, RAP-219 Meets Primary End Point
4
NeurologyLive® Friday 5 — September 12, 2025
5